Prof. Kailiang Wu 吴开良
Chief Physician, Professor
Thoracic Surgery, Shanghai Proton and Heavy Ion Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation and comprehensive treatment for lung cancer, thymic tumors, and esophageal cancer. Proton and heavy ion therapy for thoracic tumors.
Dr. Wu is Chief Physician and Professor at Fudan University Shanghai Cancer Center and Director of Thoracic Oncology at Shanghai Proton and Heavy Ion Center. Holds a doctorate in oncology. Was a visiting scholar and postdoctoral fellow at Sunnybrook Health Sciences Centre, University of Toronto (2007–2009). Has published over 110 papers, including 62 SCI-indexed articles.
Professional roles
- Vice Chair, Ion Radiotherapy Professional Committee, China Association of Medical Equipment
- Standing Committee Member, Mediastinal Tumor Professional Committee, China Anti-Cancer Association
- Member, Lung Cancer Study Group, Radiation Oncology Professional Committee, China Anti-Cancer Association
- Vice Chair, Lung Cancer Molecular Targeted and Immunotherapy Professional Committee, Shanghai Anti-Cancer Association
Name order: in Chinese the family name comes first (Wu Kailiang). Papers usually list the name as Kailiang Wu or Wu K.
Selected publications
27 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Med, 2026 (senior author): Improved Locoregional Recurrence-Free Survival With Carbon Ion Versus Photon Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer. PubMed 42717470
- Front Nutr, 2026 (senior author): Intermittent fasting alleviates irradiation-induced neuronal mitochondrial damage in mice. PubMed 42221773
- Adv Radiat Oncol, 2026 (senior author): Relative Biological Effectiveness of Carbon Ion Versus Photon Radiation Therapy for Acute Radiation-Induced Esophagitis in Locally Advanced Non-small Cell Lung Cancer Derived From Normal Tissue Complication Probability Modeling. PubMed 41853485
- Cancer Treat Res Commun, 2026 (senior author): Clinical relative biological effectiveness of carbon-ion versus photon radiotherapy derived from tumor control probability models in locally advanced non-small cell lung cancer. PubMed 42570569
- Int J Radiat Oncol Biol Phys, 2025 (senior author): Relative Biological Effectiveness Derived from NTCP Analysis of Carbon Ion vs. Photon Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. PubMed 40701500
- Radiat Oncol, 2024 (senior author): Bone matching versus tumor matching in image-guided carbon ion radiotherapy for locally advanced non-small cell lung cancer. PubMed 39696314
- Radiother Oncol, 2024 (senior author): Dose-averaged linear energy transfer within the gross tumor volume of non-small-cell lung cancer affects the local control in carbon-ion radiotherapy. PubMed 39414084
- Transl Lung Cancer Res, 2024 (senior author): The impact of different modalities of chemoradiation therapy and chemotherapy regimens on lymphopenia in patients with locally advanced non-small cell lung cancer. PubMed 38973960
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion